Neurocrine Biosciences, Inc.
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibr…
Drug Manufacturers - Specialty & Generic
US, San Diego [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group
Peer Group Analysis
Similar Stocks · Benchmarked Analysis · Peer GroupA quick analysis that compared Neurocrine Biosciences, Inc. (NBIX) to it's peer group, including competitors as well as it's industry. All monetary values in mil. except volume - volume is in thousands.
| Company | Price | Change | Volume, Avg. | Market Cap. | Revenue | Profit Net | Earnings | Free Cash Flow | Dividend Yield | P/E | EPS | Gross Margin % | Net Margin % | ROE % | ROA % | Quick Ratio % | Shares Outstanding | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Drug Manufacturers—Specialty & Generic Average | - - | - - | - - | 232,174.31 | 40,357.52 | 1,685.83 | 61,882.31 | -353.47 | 0.01 | 45.5744 | 86.22 | 0.4306 | -0.3803 | 0.01 | 0.02 | 2.3759 | - - | ||
| Maximum | - - | - - | - - | 8,626,028.00 | 528,312.00 | 32,061.00 | 1,988,352.00 | 16,134.00 | 0.08 | 2,279.6263 | 3,215.80 | 1.0000 | 1.6542 | 0.13 | 1.46 | 35.1990 | - - | ||
| Minimum | - - | - - | - - | 0.00 | 0.00 | -15,489.00 | -277,041.00 | -30,106.00 | 0.00 | -1,306.5021 | -853.08 | -3.9254 | -42.3731 | -0.31 | -0.90 | 0.0000 | - - | ||
| Amphastar Pharmaceuticals, Inc. AMPH | 45.46 | 0.91 2.04% | 394 vs. 349 | 2,185.00 | 171.00 | 43.00 | 46.00 | 452.00 | 0.9000 | 12.1264 | 0.0000 | 0.5080 | 0.2513 | 0.0642 | 0.0274 | 1.6856 | 48.00 | ||
| Evotec SE EVOTF | 6.77 | 0.00 0.00% | 1 vs. 0 | 1,200.00 | 208.00 | -20.00 | -86.00 | -496.00 | -0.1200 | -20.3101 | 0.0000 | 0.1665 | -0.0990 | -0.0187 | -0.0094 | 1.6337 | 177.00 | ||
| Alkermes plc ALKS | 28.78 | 1.08 3.90% | 2,060 vs. 1,707 | 4,656.00 | 350.00 | 36.00 | 12.00 | -1,306.00 | 0.2200 | 31.0625 | 0.0000 | 0.8256 | 0.1051 | 0.0294 | 0.0173 | 2.3141 | 161.00 | ||
| Neurocrine Biosciences, Inc. NBIX | 125.65 | 0.65 0.52% | 1,181 vs. 1,016 | 12,721.00 | 515.00 | 43.00 | 119.00 | -113.00 | 0.4300 | 81.2772 | 0.0000 | 0.9752 | 0.0842 | 0.0182 | 0.0125 | 2.3303 | 101.00 | ||
| Intra-Cellular Therapies, Inc. ITCI | 85.69 | 0.24 0.28% | 436 vs. 555 | 9,084.00 | 144.00 | -15.00 | -34.00 | -1,632.00 | -0.1600 | -108.4422 | 0.0000 | 0.9317 | -0.1052 | -0.0254 | -0.0204 | 4.5143 | 106.00 | ||
More Due Diligence
Leverage our visualization and data tables to compare over 25 years of financial data for AAPL and its peers.